If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

Share Price is delayed by 15 minutes
Get Live Data
8.60    -0.20 (-2.27%)
Bid:
8.30
Ask:
8.90
Spread: 0.60 (7.229%)
Market Cap: £56.36m
KMK Live PriceLast checked at - London Stock Exchange

Intraday Kromek Share Chart

Director Share Purchase

12 May 2021 14:50

RNS Number : 4257Y
Kromek Group PLC
12 May 2021
 

12 May 2021

 

Kromek Group plc

("Kromek" or the "Group")

 

Director Share Purchase

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, announces that Rakesh Sharma, Non-Executive Chairman, has today purchased 63,152 ordinary shares of 1 pence each in the Group ("Ordinary Shares") at a price of 15.83 pence per Ordinary Share.

 

Following this purchase, Mr Sharma has an interest in 374,856 Ordinary Shares, representing 0.09% of the issued share capital of the Group. 

 

 

For further information, please contact:

 

Kromek Group plc

 

Arnab Basu, CEO

Paul Farquhar, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Broker)

 

Max Hartley/Camilla Hume (NOMAD)

Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon (PR)

 

Harry Chathli/Claire Norbury

+44 (0)20 7618 9100

 

 

About Kromek Group plc

 

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over 150 full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

 

The Group makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rakesh Sharma

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

 

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

15.83 pence

63,152

 

d)

Aggregated information

- Aggregated volume- Price

 

 N/A

e)

Date of the transaction

12 May 2021

f)

Place of the transaction

London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADSAFLNFEFA
Date   Source Headline
14th Feb 20175:39 pmRNSHolding(s) in Company
14th Feb 20175:25 pmRNSDirector/PDMR Shareholding
14th Feb 20172:27 pmRNSHolding(s) in Company
14th Feb 201710:31 amRNSHolding(s) in Company
13th Feb 20172:04 pmRNSDirector/PDMR Shareholding
10th Feb 20173:19 pmRNSDirector/PDMR Shareholding
10th Feb 201711:51 amRNSResults of Firm Placing, Open Offer and GM
2nd Feb 20174:38 pmRNSHolding(s) in Company
1st Feb 20175:18 pmRNSHolding(s) in Company
26th Jan 201711:42 amRNSHolding(s) in Company
25th Jan 20177:00 amRNSFirm Placing and Open Offer to raise up to £21m
24th Jan 201710:15 amRNSTotal Voting Rights
22nd Dec 201611:05 amRNSSecond Price Monitoring Extn
22nd Dec 201611:00 amRNSPrice Monitoring Extension
7th Dec 20167:00 amRNSInterim Results
24th Nov 20162:15 pmRNSHolding(s) in Company
18th Nov 201612:15 pmRNSNotice of Results
2nd Nov 20167:00 amRNSNew BMD orders from existing OEM customers
19th Oct 20167:00 amRNSDelivery of 10,000 units of D3S to DARPA
17th Oct 20167:00 amRNSSix New Contract Wins Across All Business Segments
30th Sep 201612:22 pmRNSBlock listing Interim Review
21st Sep 201612:33 pmRNSResult of AGM
9th Sep 201611:46 amRNSBlock Admission
26th Aug 20163:24 pmRNSNotice of AGM and Posting of Annual Report
3rd Aug 20164:13 pmRNSHolding(s) in Company
1st Aug 20161:09 pmRNSPublication of Annual Report
29th Jul 201612:37 pmRNSTotal Voting Rights
20th Jul 201610:06 amRNSDirector/PDMR Shareholding
19th Jul 20167:00 amRNSFinal Results
23rd Jun 20167:00 amRNSHolding(s) in Company
28th Apr 20167:00 amRNSNew $12.6m contract with existing OEM customer
15th Apr 20161:27 pmRNSTotal Voting Rights
15th Apr 20161:25 pmRNSBlock listing Interim Review
14th Mar 20167:00 amRNSDirector Share Purchase
25th Feb 201611:12 amRNSHolding(s) in Company
22nd Feb 20167:00 amRNSKromek awarded further $748K contract by DARPA
22nd Feb 20167:00 amRNSSole source supplier contract from DARPA
18th Feb 20164:05 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSCapital Markets Day
20th Jan 20167:00 amRNSNew contract with long-standing customer
22nd Dec 201511:29 amRNSDirector Share Purchase
16th Dec 20157:00 amRNSDirectorate Changes
16th Dec 20157:00 amRNSInterim Results
1st Dec 20157:00 amRNSKromek enters partnership with CANBERRA Industries
5th Nov 20157:00 amRNSCross Licensing Agreement
23rd Oct 201512:49 pmRNSResult of AGM
8th Oct 20157:00 amRNSDARPA Sole Source Notice
30th Sep 20151:53 pmRNSNotice of AGM and Posting of Annual Report
28th Sep 20152:18 pmRNSBlocklisting Interim Review
28th Sep 20157:00 amRNSAppointment of Sir Peter Williams CBE as Chairman

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.